About the Journal
The African Journal of Biomedical Research (AJBR) is a leading peer‑reviewed, open‑access journal dedicated to publishing high‑quality research in biomedical sciences, allied health sciences, and interdisciplinary medical fields.
Founded in 1998 as a collaborative initiative between Laytal Communications and academic professionals in Nigeria, AJBR was established to provide a credible platform for African researchers and to promote the global dissemination of scientific knowledge.
Currently managed by Biomedical Journal Consult, Ibadan, the journal has grown into a trusted outlet for innovative and impactful biomedical research. In 2023, AJBR entered into a strategic partnership with A.R.C. Publication Services L.L.C., a globally recognized publishing organization, to strengthen its international visibility, editorial quality, and digital infrastructure. This transition, expected to be fully realized in 2024, marks a significant step towards expanding the journal’s reach and influence.
Scope of the Journal
AJBR publishes a wide range of scholarly contributions, including:
-
Original research articles
-
Comprehensive reviews and mini‑reviews
-
Short communications and rapid reports
-
Updates on conferences, workshops, and scientific meetings
Key subject areas include:
-
Public health
-
Pharmacology, toxicology, and pharmaceutics
-
Clinical medicine and internal medicine
-
Physiology and biochemistry
-
Cell biology, biotechnology, and applied microbiology
-
Related disciplines within the physical and medical sciences
Our Commitment
AJBR is guided by principles of academic integrity, ethical publishing, and rigorous peer review. The journal actively supports early‑career researchers, encourages submissions from across Africa and the global scientific community, and works to bridge research gaps in developing countries.
With over 25 years of publishing excellence, the African Journal of Biomedical Research remains committed to advancing biomedical knowledge, fostering international collaboration, and promoting open access to high‑impact scientific content.